MBOT today
$1.11+$0.06 (+5.71%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourLeaning Bearish
15 minBearish
5 minStrong Bullish
Daily trend turns up above $1.57
Key levels
Resistance$1.25
Resistance$1.16
Support$1.02
Support$0.93
Latest news & SEC filings
LegalMicrobot Medical wins patent in Canada for surgical robot attachment
NewsMicrobot Medical wins Canadian patent for surgery robot connector
All MBOT news →About Microbot Medical
Microbot Medical is a medical device company that designs robotic systems for minimally invasive endovascular procedures. Its main product is the LIBERTY Endovascular Robotic Surgical System, a single-use robot that remotely maneuvers guidewires and catheters through blood vessels, initially aimed at the peripheral vasculature market. The company also owns the NovaCross line of intraluminal revascularization devices. It operates in Israel and the United States, targeting interventional radiologists and hospitals.
Based on the company's 10-K filed Mar 26, 2026.
Nasdaq · Healthcare
Microbot Medical Inc. (MBOT)
What Is the Price Target for MBOT?
SEPT Low Target
$2.50
SEPT Mid Target
$3.25
SEPT High Target
$4.00
Analyst Consensus
$3.25
Is MBOT a Buy or Sell Right Now?
Thesis
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MBOT.
Start Free Trial →Is MBOT Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$3.10
12
Moat Score
NONE
4/9
Piotroski Score
5.9
Altman Z-Score
What Is Smart Money Doing with MBOT?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MBOT Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
60.27%
FCF Growth YoY
-48.1%
Revenue Trend
UNKNOWN
Dark Pool Trades for MBOT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for MBOT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 13:09:50 | $1.10 | 1,700 | $$2K | SELL |
| 13:08:51 | $1.10 | 4,000 | $$4K | SELL |
| 13:08:51 | $1.10 | 6,000 | $$7K | SELL |
| 13:07:02 | $1.10 | 10,000 | $$11K | SELL |
| 13:02:12 | $1.10 | 10,000 | $$11K | SELL |
5 dark pool trades shown · $$35K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Microbot Medical Inc. (MBOT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MBOT — frequently asked questions
What is MBOT stock price today?
Microbot Medical Inc. (MBOT) is at $1.11, up 5.71% (+$0.06) at the Nov 11, 2026 close.
Why is MBOT stock moving today?
Latest MBOT news — Nov 5, 2026: Microbot Medical wins patent in Canada for surgical robot attachment · Nov 5, 2026: Microbot Medical wins Canadian patent for surgery robot connector
What is the MBOT price target?
The average analyst price target for MBOT is $3.25, ranging from $3 to $4, based on 2 analysts. Latest: Citizens initiates on Oct 23, 2026.
What do analysts rate MBOT?
Analyst ratings for MBOT: 0 Buy, 5 Hold, 0 Sell — consensus Hold.
Did MBOT beat earnings?
MBOT last reported on Aug 11, 2026: EPS -$0.08 vs -$0.07 expected — a miss of 7.1%.
Does MBOT pay a dividend?
MBOT does not currently pay a dividend.
What are MBOT support and resistance levels?
Support: $1.02, $0.93, $0.85. Resistance: $1.16, $1.25, $1.35.
What are insiders doing with MBOT?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on MBOT?
Nov 5, 2026: Microbot Medical wins patent in Canada for surgical robot attachment · Nov 5, 2026: Microbot Medical wins Canadian patent for surgery robot connector